Ancient Chicken Remains Reveal the Origins of Virulence in Marek's Disease Virus

Marek's disease can first appear as a chicken that can no longer stand. The virus damages nerves and can drive aggressive tumours through several organs. Vaccination has made the disease manageable on modern farms, yet the pathogen remains widespread and unvaccinated birds can die in large numbers. The severity feels like an established property of the virus. DNA recovered from old chicken bones revealed a different history: Marek's disease virus had lived with poultry for centuries before it acquired much of its modern capacity to cause tumours.

Steven Fiddaman led the international collaboration, which brought together 37 researchers from archaeology and evolutionary biology, from virology and genomics. I was the tenth-listed author and contributed in a supporting role. The team examined chicken remains from 140 archaeological sites across Europe and the Near East. Inside a fraction of those bones were pieces of viral DNA, damaged and incomplete but still capable of carrying the history of a pathogen that left no skeleton of its own.

Recovering that history required proving that the fragments were genuinely ancient. DNA breaks into shorter pieces after death and accumulates characteristic chemical changes. Modern contamination, introduced during excavation or laboratory work, can overwhelm the tiny surviving signal. Researchers used specialised facilities and negative controls, then examined fragment length and damage patterns. The archaeological context mattered just as much. A sequence becomes historically useful only when the bone has a credible date and place.

The resulting evidence showed that Marek's disease virus was widespread among European chickens at least 1,000 years before the disease received its first formal description in 1907. That gap changed the question. The virus had not simply appeared alongside modern poultry farming. It had persisted through earlier forms of husbandry while its relationship with the host continued to evolve. Ancient genomes allowed the team to compare those earlier forms directly with modern viruses instead of inferring the entire past from present-day samples.

Such comparisons also improve the molecular clock used to estimate when viral lineages diverged. A study based only on modern genomes has to infer how quickly changes accumulated over long periods, and that rate can vary. An ancient sequence carries an approximate date of its own. It anchors part of the tree in real time, helping researchers see which genetic changes appeared along the route toward present strains and whether the pace remained constant.

Across the viral genome, 49 genes showed evidence of positive selection in the lineage leading toward modern forms. Selection means that inherited variants influenced how successfully the virus survived or reproduced, causing some to become more common. A statistical signal cannot explain the effect of every change. It identifies parts of the genome where evolution acted repeatedly. One gene stood out because decades of laboratory work had already linked it to tumour formation.

That gene is called Meq. It encodes a protein that controls the activity of genes inside infected cells and is central to the virus's ability to transform those cells into tumours. Ancient Meq sequences contained a pattern of repeated proline amino acids that differed from modern forms. Previous work had connected the loss of these repeated motifs with greater virulence. The ancient sequence therefore offered a molecular hypothesis: the older virus carried a version of this control protein less capable of driving cancerous change.

The researchers tested that hypothesis in cells. Reconstructing an ancient gene product is different from reviving the whole virus. It allows one component to be compared under controlled conditions without recreating an ancient infection. In these assays, the ancient form of Meq behaved less aggressively than modern counterparts and appeared poorly equipped to drive tumour formation. Genetics and function now pointed in the same direction. The capacity for severe disease had changed over time rather than remaining fixed.

Virulence still belongs to a relationship. A strain that causes tumours readily in one chicken line may behave differently in another. Age and co-infection influence outcome, as do housing and stress. The ancient findings identify changes in viral capacity; they do not reconstruct every illness experienced by a chicken a millennium ago. Some ancient infections may have caused disease, and skeletal remains cannot provide a complete clinical record. The strongest conclusion concerns the evolution of the pathogen's machinery.

The bones carried another sampling limit. Archaeological remains survive unevenly, and the sites available to researchers reflect where people excavated and which material institutions preserved. A virus found in several regions may have circulated more widely than the current sample shows. Absence is harder to interpret because viral DNA may decay beyond recovery. Ancient genomics gives direct evidence from particular places and periods, then relies on careful restraint when extending beyond them.

The timing invites questions about modern poultry production. Chicken populations grew dramatically during the twentieth century, flock structures changed and vaccines altered which infections produced illness. Each development could affect viral evolution. Some Marek's vaccines prevent disease more effectively than they prevent infection or transmission, creating a possible route by which harmful strains continue circulating. The study did not isolate one historical pressure as the cause of every genetic change. It supplied dated evidence with which competing explanations can now be tested.

That distinction matters because simple evolutionary stories are seductive. A claim that vaccination made the virus more dangerous would exceed what these ancient genomes demonstrate. Vaccination has prevented enormous losses and improved animal welfare. Researchers can still ask how different products shape transmission and whether certain viral variants gain an advantage in vaccinated flocks. The useful response is closer surveillance and vaccine design informed by evolution, rather than abandoning a tool that protects birds.

Virulence does not always evolve upward. A pathogen gains an advantage by reproducing and reaching new hosts, and severe disease may help or hinder that route depending on how transmission occurs. Marek's disease virus spreads from feather follicles, so a bird can release virus even when vaccination prevents obvious illness. That biology makes increasing harm possible under some conditions without turning it into an evolutionary rule. The ancient record shows what happened in this lineage, not a destination toward which every virus must move.

Archaeology made this line of inquiry possible. Animal bones are often studied to understand diet or trade, while the genetic material inside them can preserve the pathogens that moved alongside people. Saving well-documented remains gives future researchers access to questions that current technology cannot yet answer. The value extends beyond spectacular human epidemics. A poultry virus with major economic and welfare consequences can reveal general principles about how virulence emerges.

Modern surveillance can now look for the genes and mechanisms highlighted by the ancient comparison. Sequencing strains from different farming systems may show whether changes in Meq or other selected genes are spreading. Cell experiments can test how those changes affect viral growth and tumour pathways. Studies in birds can connect the molecular effect with transmission and disease. Ancient DNA narrows the search by showing where long-term evolution left its clearest marks.

The economic stakes make that search practical as well as historical. Marek's disease costs poultry production worldwide through vaccination and losses when control fails. A strain capable of breaking through existing protection can affect food supply and farmer livelihoods before its evolutionary significance is fully understood. Surveillance informed by candidate genes may help detect meaningful change earlier, especially when it is paired with observations of disease in flocks.

The work also changes the timescale on which disease control is imagined. A vaccine campaign is judged across seasons, while pathogen evolution may continue across generations of hosts. Policies that reduce disease today can be paired with monitoring designed to detect slower change. The goal is a system capable of learning while the virus responds. History becomes a form of preparedness when it reveals which parts of a pathogen have changed before.

A chicken bone cannot preserve paralysis or the course of a tumour. It can preserve enough viral DNA to show that the pathogen inside an ancient flock was biologically different from the one confronting farmers now. By joining those fragments with modern experiments, the study turned a thousand years of absence into evidence. Marek's disease did not arrive with its present ferocity fully formed. Its virulence has a history, which means science can study the forces that shaped it.